The extraordinary general meeting of Marksans Pharma will be held on 10 September 2008 to offer, issue and allot upto 84,00,241 equity shares of Re 1 each fully paid at a premium of Rs 19.12 per equity share aggregating to Rs 16,89,87,000 in the share capital of the company to Barnacle LLC on preferential allotment basis.
Showing posts with label Marksans Pharma. Show all posts
Showing posts with label Marksans Pharma. Show all posts
Wednesday, August 20, 2008
Subscribe to:
Posts (Atom)
